Med tech lender MidCap readies for potential buyout

MidCap Financial, a firm that lends to devicemakers, pharmaceutical companies and other healthcare-related ventures, is set to be bought by Apollo Investment Corp. for about $500 million, according to a Bloomberg report. The deal, yet to be finalized, is still under wraps, Bloomberg's sources said. Another investor, Fifth Third Bancorp, had also expressed interest in MidCap, which opened its doors in 2008. Story

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.